93 percent of advanced leukemia patients in remission after immunotherapy

Posted by on April 28, 2016 2:12 am
Categories: Science

Twenty-seven of 29 patients with an advanced type of leukemia that had proved resistant to multiple other forms of therapy went into remission after their T cells (disease-fighting immune cells) were genetically engineered to fight their cancers. This study is the first CAR T-cell trial to infuse patients with an even mixture of two types of T cells (helper and killer cells, which work together to kill cancer).

Leave a Reply

Your email address will not be published. Required fields are marked *